Investigating the Potential Role of Aerosolized Retinoic Acid, a Potent Vitamin A Metabolite for Treating COVID-19 Anosmia and Retinoic Acid Insufficiency .A Novel Approach for Regaining Sense of Smell.

NCT05002530 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10000

Enrollment

OTHER

Sponsor class

Conditions

Post COVID-19 Anosmia (Loss of Smell)

Interventions

DRUG: Aerosolized 13 cis retinoic acid plus Vitamin D
DRUG: Aerosolized All trans retinoic acid plus Vitamin D
OTHER: Standard therapy

Sponsor

Kafrelsheikh University

Collaborators

[object Object]
[object Object]
[object Object]